Literature DB >> 10593355

Safe and effective management of the obese patient.

M L Collazo-Clavell1.   

Abstract

The prevalence of overweight and obesity has increased dramatically in the recent decades, and obesity is now a major public health problem. Obesity negatively influences an individual's health by increasing mortality and raising the risk for multiple medical conditions such as type 2 diabetes mellitus, hypertension, dyslipidemia, and coronary heart disease. In addition, the obese individual is often the brunt of social discrimination. Weight loss has been shown to reduce the risk for many of these comorbid conditions. A multifaceted approach to the obese patient should include identifying potential causes for weight gain, outlining medical conditions that would benefit by weight loss, and tailoring a weight loss program that is safe and effective for the individual. Components of a successful weight loss program include dietary intervention, recommendations for physical activity, behavior modification, and, in a select group of patients, pharmacologic or surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593355     DOI: 10.4065/74.12.1255

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

Review 1.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

2.  Bariatric surgery: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-01-01

Review 3.  Obesity and deep brain stimulation: an overview.

Authors:  Rahul Kumar; Constance V Simpson; Clifford A Froelich; Brandon C Baughman; Andrew J Gienapp; Karl A Sillay
Journal:  Ann Neurosci       Date:  2015-07

4.  A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.

Authors:  Barbara Grube; Pee-Win Chong; Kai-Zhia Lau; Hans-Dieter Orzechowski
Journal:  Obesity (Silver Spring)       Date:  2013-01       Impact factor: 5.002

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.